The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
TFOS DEWS II Introduction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
DED is a multifactorial malady of the ocular surface characterized by disruption in tear film homeostasis accompanied by ocular symptoms.
“DED is a multifactorial malady of ocular surface characterized by the disruption in tear film homeostasis accompanied by ocular symptoms.”
From From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics (2025) · cites this paper as [118]
Pivotal etiological factors of DED comprise tear film instability, hyperosmolarity, inflammation, impairment to the ocular surface, and neurosensory abnormalities.
“Pivotal etiological factors comprise the tear film instability, hyperosmolarity, inflammation, impairment to the ocular surface as well as neurosensory abnormalities [118].”
From From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics (2025) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · The Ocular Surface · doi:10.1016/s1542-0124(12)70081-2 · Cited by 3,299
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
Lemp, M. A. (1995) · PubMed · Cited by 1,705
Flagged first, then by citations
Cited by
Sorted by citations
From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics
Sun, M., Wang, J., Fan, W., Wang, K., Wang, Y., Zhang, J., Ding, S., Zhang, C., Feng, Z., Wang, Y.-G., et al. (2025) · Materials today. Bio · doi:10.1016/j.mtbio.2025.102537 · Cited by 7
Metadata
- Authors
- Nelson, J. D., Craig, J. P., Akpek, E. K., Azar, D. T., Belmonte, C., Bron, A. J., Clayton, J. A., Dogru, M., Dua, H. S., Foulks, G. N., Gomes, J. A. P., Hammitt, K. M., Holopainen, J., Jones, L., Joo, C.-K., Liu, Z., Nichols, J. J., Nichols, K. K., Novack, G. D., Sangwan, V., Stapleton, F., Tomlinson, A., Tsubota, K., Willcox, M. D. P., Wolffsohn, J. S., & Sullivan, D. A.
- Affiliations
- University of Minnesota (US)
- University of Auckland (NZ)
- Johns Hopkins University (US)
- University of Illinois Chicago (US)
- Universitat de Miguel Hernández d'Elx (ES)
- University of Oxford (GB)
- National Institutes of Health (US)
- University of Nottingham (GB)
- University of Louisville (US)
- Sjögren’s Foundation (US)
- University of Helsinki (FI)
- University of Waterloo (CA)
- Catholic University of Korea (KR)
- Xiamen University (CN)
- University of Alabama at Birmingham (US)
- University of California, Davis (US)
- UNSW Sydney (AU)
- Glasgow Caledonian University (GB)
- Keio University (JP)
- Aston University (GB)
- Massachusetts Eye and Ear Infirmary (US)
- Corresponding author
- Nelson, J. Daniel
- ORCID
- Venue
- The Ocular Surface
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 15
- Issue
- 3
- Pages
- 269-275
- ISSN
- 1542-0124 (ISSN-L)
- OpenAlex
- W2738794130
- Cited by
- 287
- References
- 2
- Citations by year
- 2026: 16 · 2025: 35 · 2024: 37 · 2023: 37 · 2022: 35 · 2021: 45 · 2020: 32 · 2019: 28 · 2018: 15 · 2017: 6
- FWCI
- 20.80
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- The Ocular Surface (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Aston Publications Explorer (Aston University) (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- ResearchOnline (Glasgow Caledonian University) (submittedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Johnson and Johnson Vision Care
- Allergan Foundation
- Shire
- Novartis
- Alcon
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
- Keywords
- tear film, ocular surface disease, tear film break-up time, tear meniscus height, tear osmolarity, tear film thickness
- MeSH terms
- Congresses as Topic, Directories as Topic, Humans, Ophthalmology, Societies, Medical, Dry Eye Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
